"End Stage Liver Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.
| Descriptor ID |
D058625
|
| MeSH Number(s) |
C06.552.308.500.177
|
| Concept/Terms |
Chronic Liver Failure- Chronic Liver Failure
- Chronic Liver Failures
- Failure, Chronic Liver
- Failures, Chronic Liver
- Liver Failures, Chronic
- Liver Failure, Chronic
|
Below are MeSH descriptors whose meaning is more general than "End Stage Liver Disease".
Below are MeSH descriptors whose meaning is more specific than "End Stage Liver Disease".
This graph shows the total number of publications written about "End Stage Liver Disease" by people in this website by year, and whether "End Stage Liver Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 2 | 1 | 3 |
| 2012 | 5 | 2 | 7 |
| 2013 | 7 | 1 | 8 |
| 2014 | 4 | 0 | 4 |
| 2015 | 4 | 0 | 4 |
| 2016 | 6 | 2 | 8 |
| 2017 | 7 | 1 | 8 |
| 2018 | 10 | 1 | 11 |
| 2019 | 12 | 1 | 13 |
| 2020 | 13 | 3 | 16 |
| 2021 | 12 | 1 | 13 |
| 2022 | 6 | 0 | 6 |
| 2023 | 6 | 0 | 6 |
| 2024 | 6 | 9 | 15 |
| 2025 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "End Stage Liver Disease" by people in Profiles.
-
Post-liver transplantation outcomes in acute-on-chronic liver failure: Impact of alcohol as a precipitant and etiology of chronic liver disease. Liver Transpl. 2026 Jan 01; 32(1):86-94.
-
What are we waiting for: Serious bacterial infections in children prior to liver transplant are associated with high morbidity but not expedited transplant. J Pediatr Gastroenterol Nutr. 2025 Sep; 81(3):634-643.
-
Renal replacement therapy in liver transplant-ineligible patients. Liver Transpl. 2026 Jan 01; 32(1):95-100.
-
Frailty in Pediatric Liver Disease May Be Associated With an Increased Incidence of Readmissions After Pediatric Liver Transplantation. Pediatr Transplant. 2025 May; 29(3):e70077.
-
Impact of Glucagon-like Peptide-1 Receptor Agonists on Metabolic Health in Liver Transplant Recipients. Transplantation. 2025 09 01; 109(9):e501-e507.
-
Survival outcomes following liver retransplantation (reSOFT) score: A model predicting survival after adult liver retransplantation. Liver Transpl. 2025 Jul 01; 31(7):906-915.
-
Myosteatosis Is Associated With Frailty and Poor Physical Function in Patients Undergoing Liver Transplant Evaluation: A Cohort Study. Clin Transplant. 2024 Dec; 38(12):e70034.
-
Is the Transplantation of Elderly and DCD Donors in Low MELD Recipients Justified: An Intent-to-treat Analysis. Transplantation. 2025 05 01; 109(5):823-831.
-
Prospective evaluation of cystatin C in the assessment of kidney dysfunction and survival in liver transplant candidates. Liver Transpl. 2025 May 01; 31(5):571-583.
-
Constructing an Intent-to-Treat Score Index to Predict Survival Outcomes in Pediatric Liver Transplant Recipients. Pediatr Transplant. 2024 Aug; 28(5):e14816.